Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$821,104,505
-$7,732,269 QoQ
Shares Held
5,239,309
-3.4% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#5
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $1,754,958,212 across 10 Drug Manufacturers - General names. NVS ranks #2 (46.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
18,594,352 | $891,413,233 | |
| 2 | NVS |
Novartis AG
This page
|
5,239,309 | $821,104,505 | |
| 3 | ABBV |
AbbVie Inc.
|
43,544 | $10,957,411 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
170,634 | $9,831,930 | |
| 5 | MRK |
Merck & Co., Inc.
|
58,514 | $7,519,048 | |
| 6 | LLY |
ELI LILLY & Co
|
5,956 | $7,143,805 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
46,442 | $5,867,481 | |
| 8 | JNJ |
Johnson & Johnson
|
2,741 | $696,131 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $821,104,505 | 5,239,309 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $828,836,774 | 5,426,100 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $763,002,221 | 5,534,215 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $726,468,186 | 5,664,911 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $675,426,511 | 5,581,576 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $613,484,807 | 5,503,093 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $542,694,074 | 5,576,961 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $663,623,761 | 5,769,638 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $632,945,473 | 5,945,383 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $572,445,431 | 5,917,972 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $606,819,602 | 6,009,900 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $617,945,606 | 6,066,617 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $637,247,658 | 6,315,010 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $607,857,708 | 6,607,149 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $993,020,938 | 10,945,998 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,134,810,448 | 14,929,752 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,308,965,646 | 15,485,220 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $1,518,705,659 | 17,307,187 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,565,150,217 | 17,893,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,548,867,811 | 18,939,445 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,735,347,300 | 19,019,589 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,689,835,057 | 19,768,777 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,899,717,149 | 20,117,729 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $913,580,020 | 10,505,750 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $920,923,353 | 10,544,119 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $858,119,482 | 10,407,756 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||